Life Sciences Tools and Services
Company Overview of WaveSense, Inc.
WaveSense, Inc. engages in the development, manufacture, and marketing of analytical nanotechnologies for use in cellular and molecular assay markets. The company offers EpiSep, a lateral flow separations platform that is used for the detection and characterization of live cells, proteins, and genes. It also provides EpiSep slides, super paramagnetic particles, conjugate antibodies, preserved tumor cells, buffers, start up kits, ready-to-use kits, and accessories. The company offers its products for drug discovery and rare cell detection in blood and bone marrow, as well as for infectious disease, bio-defense, veterinary diagnostic, and regenerative medicine test applications. Its products a...
15339 Barranca Parkway
Irvine, CA 92618
Founded in 1999
Key Executives for WaveSense, Inc.
Founder and Chief Executive Officer
Compensation as of Fiscal Year 2014.
WaveSense, Inc. Key Developments
WaveSense, Inc. Announces Launch of a New Application that Targets, Enriches and Isolates Cells Obtained from DRE/DRM
Apr 2 15
WaveSense, Inc. announced the availability of the latest addition to its line of cell enrichment applications delivered through its patented EpiSep medical product line. The Cell Enrichment from Expressed Prostate Secretions application captures, enriches and isolates targeted cells contained in prostate secretions obtained through digital rectal examination (DRE) or digital rectal massage (DRM). The EPS application is an important new addition to the WaveSense's Urology application suite that already includes cell enrichment from urine. The Cell Enrichment from Expressed Prostate Secretions application is the latest addition to a growing list of EpiSep HStargeted cell enrichment and isolation applications, including its Cell Enrichment from Urine (Uro-1) and Cell Enrichment from Bone Marrow (CD138) applications.
Applied Spectral Imaging, Ltd. and WaveSense, Inc. to Cooperate in Molecular Pathology and Cytogenetic Fish
Apr 22 13
Applied Spectral Imaging, Ltd. and WaveSense, Inc. have entered into an agreement in which both companies will engage in combined sales and marketing of the GenASIs imaging and analysis instrument by ASI and the EpiSEP cell recovery and enrichment solution by WaveSense. The combined solution delivers an integrated cell capturing solution and computerized instrument to detect, image and analyze the captured cells.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries